Clinical Trial Update: Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an adjuvanted A(H1N1) influenza vaccine with a non-adjuvanted vaccine in patients with invasive solid tumors to evaluate immunogenicity,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Malignant Neoplasms

Drugs mentioned

• Influenza vaccine, A(H1N1) adjuvanted
• Influenza vaccine, A(H1N1) non-adjuvanted

Snippet

Sponsor: Chiltern Pesquisa Clinica Ltda | Conditions: H1N1 Influenza Virus, Invasive Solid Tumors | Phase 3 | Status: COMPLETED